Notes on ACTA from a Consumer Perspective 1. Is ACTA really an anti-counterfeiting agreement? Consumers are in favour of measures that confront commercial fraud, especially when it affects public safety and health, the quality of consumer products or the false…
Category: Uncategorized
Some simple notes for ACTA debate
THE EUROPEAN COMMISSION REJECTS ASKING FOR A EUROPEAN COURT OF JUSTICE OPINION ON the LEGALITY OF ACTA. DESPITE MANY DOUBTS AND LEGAL UNCERTAINTIES IN THE ACTA TEXT THE EC REFUSES TO ALLOW A European Court opinion on its legality and…
Copyright extremists Gallo and Barnier now block orphans
MEP Gallo´s and Commissioner Barnier´s crusade against access to our cultural legacy French Member of the European Parliament Marielle Gallo is leading a destructive political campaign to close the door on easing access to the vast cultural legacy of millions…
ACTA´s Democratic Vacuum in EU
European Digital Rights on ACTA´s Democratic Vacuum The European Parliament has given its legal service the task of explaining why a circle is a square – or rather why ACTA is simultaneously in line with existing EU legal provisions, while…
Shoving ACTA down the throat of the European Parliament
As ACTA D-day approaches the debate heats up in Brussels. Today French Sarkozyist MEP Marielle Gallo started leading the forward charge of the music and entertainment lobbyist light brigade. MEPs are already being bullied into rushing into parliamentary approval of…
If you can´t beat them, join them and try to spoil it
European Commission and the right to read: If you can´t beat them, join them and try to spoil it Last week in Geneva at WIPO the EU was dragged kicking and screaming into a concrete textual debate…
Generic drug disappears, price goes up 1.100%
Price Shock: antidepressive drug has gone up with 1,100 percent. In the last two weeks the price of the antidepressive drug Sertraline has increased dramaticallyin Denmark. The Danish Minister of Health is left speechless. The drug Sertraline produced the pharmaceutical…
EU research: We all invest, who gets the return?
EU biomedical innovation policy and the public good
EU Policy Opportunities in Biomedical Innovation and the Public Good November 2011 EXECUTIVE SUMMARY TransAtlantic Consumers Dialogue Health Action International Knowledge management is becoming increasingly central to our social…